Exane Derivatives’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $166 | Hold |
471
| – | – | ﹤0.01% | 685 |
|
|
2022
Q1 | $338 | Hold |
471
| – | – | ﹤0.01% | 909 |
|
|
2021
Q4 | $1.06K | Hold |
471
| – | – | ﹤0.01% | 691 |
|
|
2021
Q3 | $1.36K | Hold |
471
| – | – | ﹤0.01% | 811 |
|
|
2021
Q2 | $1.57K | Hold |
471
| – | – | ﹤0.01% | 815 |
|
|
2021
Q1 | $1.59K | Hold |
471
| – | – | ﹤0.01% | 678 |
|
|
2020
Q4 | $1.32K | Hold |
471
| – | – | ﹤0.01% | 644 |
|
|
2020
Q3 | $1.18K | Hold |
471
| – | – | ﹤0.01% | 578 |
|
|
2020
Q2 | $6.4K | Hold |
471
| – | – | ﹤0.01% | 413 |
|
|
2020
Q1 | $3.57K | Hold |
471
| – | – | ﹤0.01% | 447 |
|
|
2019
Q4 | $3.52K | Hold |
471
| – | – | ﹤0.01% | 437 |
|
|
2019
Q3 | $1.85K | Hold |
471
| – | – | ﹤0.01% | 469 |
|
|
2019
Q2 | $2.28K | Hold |
471
| – | – | ﹤0.01% | 477 |
|
|
2019
Q1 | $3.86K | Hold |
471
| – | – | ﹤0.01% | 395 |
|
|
2018
Q4 | $2.6K | Buy |
+471
| New | +$2.6K | ﹤0.01% | 475 |
|